ZURA BIO LTD (ZURA)
KYG9TY5A1016 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to ZURA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 589.19% above the current price.
ZURA was analyzed by 15 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ZURA.
In the previous month the buy percentage consensus was at a similar level.
ZURA was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-04 | Leerink Partners | Initiate | Outperform |
| 2024-10-21 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-10-18 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-09-05 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-08-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-17 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-12 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-05-10 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-05-03 | Piper Sandler | Initiate | Overweight |
| 2024-04-01 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-10-10 | Ladenburg Thalmann | Initiate | Buy |
| 2023-08-25 | Oppenheimer | Initiate | Outperform |
| 2023-08-15 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-06-22 | Guggenheim | Initiate | Buy |
| 2023-06-14 | Chardan Capital | Initiate | Buy |
| 2023-05-24 | Raymond James | Initiate | Strong Buy |